Sec Form 4 Filing - Fong Ivan K @ Medtronic plc - 2023-07-31

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Fong Ivan K 2. Issuer Name and Ticker or Trading Symbol Medtronic plc [ MDT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) EVP GENERAL COUNSEL & SECR (Last) (First) (Middle) 710 MEDTRONIC PARKWAY 3. Date of Earliest Transaction (MM/DD/YY) 07/31/2023 (Street) MINNEAPOLIS, MN55432 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary Shares 07/31/2023 A 7,977 ( 1 ) A $ 0 40,807 ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Performance Share Units ( 3 ) 07/31/2023 A 19,941 ( 4 ) ( 5 ) ( 5 ) Performance Share Units 19,941 $ 0 19,941 D Stock Option (Right to Buy) $ 87.76 07/31/2023 A 56,162 ( 6 ) 07/31/2033 Ordinary Shares 56,162 $ 0 56,162 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Fong Ivan K 710 MEDTRONIC PARKWAY MINNEAPOLIS, MN55432 EVP GENERAL COUNSEL & SECR Signatures /s/ Thomas L. Osteraas, attorney-in-fact 08/02/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. ( 2 )Includes 641 units acquired through dividend reinvestment since the last report filed by the reporting person. ( 3 )Each performance share unit represents a contingent right to receive one share of Medtronic common stock. ( 4 )The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,941 shares will be issued. If maximum performance metrics are achieved, 39,882 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. ( 5 )Vests on July 31, 2026. ( 6 )These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.